share_log

Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.05%)

Feb 9, 2023 11:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more